Mittermaier, Mirja

SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis

Wendisch, D., Dietrich, O., Mari, T., von Stillfried, S., Ibarra, I. L., Mittermaier, M., Mache, C., Chua, R. L., Knoll, R., Timm, S., et al. (2021) · Cell

COVID-19 Clinical Research StudiesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 528

Bias in AI-based models for medical applications: challenges and mitigation strategies

Mittermaier, M., Raza, M. M., & Kvedar, J. C. (2023) · npj Digital Medicine

Ethics and Social Impacts of AIArtificial Intelligence in Healthcare and Education

Cited by 372

A time-resolved proteomic and prognostic map of COVID-19

Demichev, V., Tober-Lau, P., Lemke, O., Nazarenko, T., Thibeault, C., Whitwell, H., Röhl, A., Freiwald, A., Szyrwiel, L., Ludwig, D., et al. (2021) · Cell Systems

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 200

Challenges and Potential of Using Digital Biomarkers in Healthcare and Clinical Trials

Lieberwirth, J. K., Mittermaier, M., & Stern, A. D. (2026) · Communications Medicine

Mobile Health and mHealth ApplicationsHealthcare Technology and Patient Monitoring

Cited by 13